8-K//Current report
Clarus Therapeutics Holdings, Inc. 8-K
Accession 0001213900-22-064699
CIK 0001817944operating
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 4:10 PM ET
Size
220.8 KB
Accession
0001213900-22-064699
Documents
- 8-Kea167269-8k_clarusthera.htmPrimary
FORM 8-K
- EX-99.1ea167269ex99-1_clarusthera.htm
PRESS RELEASE OF CLARUS THERAPEUTICS HOLDINGS, INC., DATED OCTOBER 18, 2022.
- EX-101.SCHcrxt-20221014.xsd
XBRL SCHEMA FILE
- EX-101.LABcrxt-20221014_lab.xml
XBRL LABEL FILE
- EX-101.PREcrxt-20221014_pre.xml
XBRL PRESENTATION FILE
- GRAPHICimage_001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLea167269-8k_clarusthera_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-22-064699-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001817944
Filing Metadata
- Form type
- 8-K
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 4:10 PM ET
- Size
- 220.8 KB